Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In a single piece, he concisely captures: the state of the field the most important clinical trials where the pipeline is headed These Clinical trials are raising the bar and expanding future treatment options: Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly semaglutide + once-weekly insulin Even more exciting
Acylation chemistry attacks lysine side chains, and with two lysines in the sequence the reaction yields a mixture of positional isomers that are hard to separate and hard to detect
#CNS #Neuroscience #Neurology #Neurodegeneration #Neuroinflammation #Neuromuscular #Neuropsychiatry #Alzheimers #Parkinsons To view or add a comment, sign in Explore related topics Explore content categories
Longer-term scale depends on affordability and movement into reimbursed care
